Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Gold

Showing results (161-170 of 234) with videos related to

Pageof 24
Sort By:
European Journal of Immunology|February 1, 2024
Actinin-4 controls survival signaling in B cells by limiting the lateral mobility of B-cell antigen receptorsSaed Alsouri, Ashley Ambrose, Nikolaos Mougios, et al.
Journal of Drugs in Dermatology : JDD|April 14, 2021
Four-Week Daily Calcipotriene/Betamethasone Dipropionate Foam Is Highly Efficacious in Patients With Psoriasis (PSO-LONG Lead-in Phase)Richard B Warren, Michael Gold, Melinda Gooderham, et al.
Aesthetic Surgery Journal|August 1, 2025
Multicenter, Randomized Split-Face Trial of a Crosslinked Hyaluronic Acid Filler With Lidocaine for Nasolabial Fold CorrectionKonstantin Frank, Jeanine Downie, Michael Gold, et al.
Journal of Drugs in Dermatology : JDD|March 5, 2024
Early and Sustained Acne Lesion Reductions With Fixed-Dose Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% GelJulie C Harper, Leon H Kircik, Michael Gold, et al.
JACC. Clinical Electrophysiology|September 7, 2023
Impact of Age on Subcutaneous Implantable Cardioverter-Defibrillator in a Large Patient Cohort: Mid-Term Follow-UpRaul Weiss, Bradley P Knight, Mikhael El-Chami, et al.
The Clinical Journal of Pain|June 23, 2009
Predictors of placebo response in pooled lamotrigine neuropathic pain clinical trialsMichael C Irizarry, David J Webb, Zahid Ali, et al.
Journal of the American Academy of Dermatology|September 1, 2023
Clindamycin phosphate 1.2%/adapalene 0.15%/benzoyl peroxide 3.1% gel for moderate-to-severe acne: Efficacy and safety results from two randomized phase 3 trialsLinda Stein Gold, Edward Lain, James Q Del Rosso, et al.
Alzheimer'S & Dementia (New York, N. Y.)|January 3, 2025
Understanding recent advances in non-amyloid/non-tau (NANT) biomarkers and therapeutic targets in Alzheimer's diseaseLinda J Van Eldik, Eric R Siemers, Emily C Collins, et al.
Brain : a Journal of Neurology|February 2, 2023
Tilavonemab in early Alzheimer's disease: results from a phase 2, randomized, double-blind studyHana Florian, Deli Wang, Steven E Arnold, et al.
Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc|September 27, 2003
Prevalence of sensing abnormalities in dual chamber implantable cardioverter defibrillatorsMohammad Saeed, Anna Jin, Gregory Pontone, et al.
Pageof 24

Showing results (161-170 of 234) with videos related to

Sort By:
Pageof 24
European Journal of Immunology|February 1, 2024
Actinin-4 controls survival signaling in B cells by limiting the lateral mobility of B-cell antigen receptorsSaed Alsouri, Ashley Ambrose, Nikolaos Mougios, et al.
Journal of Drugs in Dermatology : JDD|April 14, 2021
Four-Week Daily Calcipotriene/Betamethasone Dipropionate Foam Is Highly Efficacious in Patients With Psoriasis (PSO-LONG Lead-in Phase)Richard B Warren, Michael Gold, Melinda Gooderham, et al.
Aesthetic Surgery Journal|August 1, 2025
Multicenter, Randomized Split-Face Trial of a Crosslinked Hyaluronic Acid Filler With Lidocaine for Nasolabial Fold CorrectionKonstantin Frank, Jeanine Downie, Michael Gold, et al.
Journal of Drugs in Dermatology : JDD|March 5, 2024
Early and Sustained Acne Lesion Reductions With Fixed-Dose Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% GelJulie C Harper, Leon H Kircik, Michael Gold, et al.
JACC. Clinical Electrophysiology|September 7, 2023
Impact of Age on Subcutaneous Implantable Cardioverter-Defibrillator in a Large Patient Cohort: Mid-Term Follow-UpRaul Weiss, Bradley P Knight, Mikhael El-Chami, et al.
The Clinical Journal of Pain|June 23, 2009
Predictors of placebo response in pooled lamotrigine neuropathic pain clinical trialsMichael C Irizarry, David J Webb, Zahid Ali, et al.
Journal of the American Academy of Dermatology|September 1, 2023
Clindamycin phosphate 1.2%/adapalene 0.15%/benzoyl peroxide 3.1% gel for moderate-to-severe acne: Efficacy and safety results from two randomized phase 3 trialsLinda Stein Gold, Edward Lain, James Q Del Rosso, et al.
Alzheimer'S & Dementia (New York, N. Y.)|January 3, 2025
Understanding recent advances in non-amyloid/non-tau (NANT) biomarkers and therapeutic targets in Alzheimer's diseaseLinda J Van Eldik, Eric R Siemers, Emily C Collins, et al.
Brain : a Journal of Neurology|February 2, 2023
Tilavonemab in early Alzheimer's disease: results from a phase 2, randomized, double-blind studyHana Florian, Deli Wang, Steven E Arnold, et al.
Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc|September 27, 2003
Prevalence of sensing abnormalities in dual chamber implantable cardioverter defibrillatorsMohammad Saeed, Anna Jin, Gregory Pontone, et al.
Pageof 24